Β2 adrenergic receptor, protein kinase a (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in alzheimer disease models

Journal of Biological Chemistry

Volumn 288, Issue 15, 2013, Pages 10298-10307

  Wang, Dayong ^a   Fu, Qin ^a,b,c   Zhou, Yuan ^a   Xu, Bing ^b   Shi, Qian ^a,b   Igwe, Benedict ^a   Matt, Lucas ^b   Hell, Johannes W ^b   Wisely, Elena V ^d   Oddo, Salvatore ^d   Xiang, Yang K ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTORS; ALZHEIMER DISEASE; C-JUN N-TERMINAL KINASE; POTENTIAL MECHANISM; PRESYNAPTIC; PROTEIN KINASE A; SIGNALING PATHWAYS; TAU PATHOLOGY;

C (PROGRAMMING LANGUAGE); NEURODEGENERATIVE DISEASES;

PATHOLOGY;

AMYLOID PRECURSOR PROTEIN; BETA ADRENERGIC RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE 3ALPHA; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUTANT PROTEIN; PRESENILIN 1; RETINA S ANTIGEN; SERINE; STRESS ACTIVATED PROTEIN KINASE; TAU PROTEIN; THREONINE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DENDRITIC SPINE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE DELETION; LEARNING DISORDER; MEMORY DISORDER; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; PATTERN RECOGNITION; PREFRONTAL CORTEX; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYNAPSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ARRESTIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DENDRITIC SPINES; DISEASE MODELS, ANIMAL; GLYCOGEN SYNTHASE KINASE 3; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUTATION; PREFRONTAL CORTEX; RECEPTORS, ADRENERGIC, BETA-2; SYNAPSES;

EID: 84876270805     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.415141     Document Type: Article

References (37)

1. Vogel, J., Anand, V. S., Ludwig, B., Nawoschik, S., Dunlop, J., and Braithwaite, S. P. (2009) The JNK pathway amplifies and drives subcellular changes in tau phosphorylation. Neuropharmacology 57, 539-550
2. Hall, G. F., Chu, B., Lee, G., and Yao, J. (2000) Human tau filaments induce microtubule and synapse loss in an in vivo model of neurofibrillary degenerative disease. J. Cell Sci. 113, 1373-1387
3. Thies, E., and Mandelkow, E. M. (2007) Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1. J. Neurosci. 27, 2896-2907
4. Mattson, M. P. (2004) Pathways towards and away from Alzheimer's disease. Nature 430, 631-639
5. Giuffrida, M. L., Caraci, F., Pignataro, B., Cataldo, S., De Bona, P., Bruno, V., Molinaro, G., Pappalardo, G., Messina, A., Palmigiano, A., Garozzo, D., Nicoletti, F., Rizzarelli, E., and Copani, A. (2009) β-Amyloid monomers are neuroprotective. J. Neurosci. 29, 10582-10587
6. Ma, Q. L., Yang, F., Rosario, E. R., Ubeda, O. J., Beech, W., Gant, D. J., Chen, P. P., Hudspeth, B., Chen, C., Zhao, Y., Vinters, H. V., Frautschy, S. A., and Cole, G. M. (2009) β-Amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling. Suppression by omega-3 fatty acids and curcumin. J. Neurosci. 29, 9078-9089
7. Zempel, H., Thies, E., Mandelkow, E., and Mandelkow, E. M. (2010) Aβoligomers cause localized Ca(2β) elevation, missorting of endogenous tau into dendrites, tau phosphorylation, and destruction of microtubules and spines. J. Neurosci. 30, 11938-11950
8. Mitsuyama, F., Futatsugi, Y., Okuya, M., Karagiozov, K., Peev, N., Kato, Y., Kanno, T., Sano, H., and Koide, T. (2009) Amyloid β. A putative intraspinal microtubule-depolymerizer to induce synapse-loss or dendritic spine shortening in Alzheimer's disease. Ital. J. Anat. Embryol. 114, 109-120
9. Mitsuyama, F., Futatsugi, Y., Okuya, M., Kawase, T., Karagiozov, K., Kato, Y., Kanno, T., Sano, H., Nagao, S., and Koide, T. (2012) Stimulation-dependent intraspinal microtubules and synaptic failure in Alzheimer's disease. A review. Int. J. Alzheimers Dis. 2012, 519682
10. Bittner, T., Fuhrmann, M., Burgold, S., Ochs, S. M., Hoffmann, N., Mitteregger, G., Kretzschmar, H., LaFerla, F. M., and Herms, J. (2010) Multiple events lead to dendritic spine loss in triple transgenic Alzheimer's disease mice. PLoS ONE 5, e15477
11. Hoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., Pitstick, R., Carlson, G. A., Lanier, L. M., Yuan, L. L., Ashe, K. H., and Liao, D. (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68, 1067-1081
12. Violin, J. D., DiPilato, L. M., Yildirim, N., Elston, T. C., Zhang, J., and Lefkowitz, R. J. (2008) β2-adrenergic receptor signaling and desensitization elucidated by quantitative modeling of real time cAMP dynamics. J. Biol. Chem. 283, 2949-2961
13. Rosenberg, P. B., Mielke, M. M., Tschanz, J., Cook, L., Corcoran, C., Hayden, K. M., Norton, M., Rabins, P. V., Green, R. C., Welsh-Bohmer, K. A., Breitner, J. C., Munger, R., and Lyketsos, C. G. (2008) Effects of cardiovascular medications on rate of functional decline in Alzheimer disease. Am. J. Geriatr. Psychiatry 16, 883-892
14. Ni, Y., Zhao, X., Bao, G., Zou, L., Teng, L., Wang, Z., Song, M., Xiong, J., Bai, Y., and Pei, G. (2006) Activation of β2-adrenergic receptor stimulates β-secretase activity and accelerates amyloid plaque formation. Nat. Med. 12, 1390-1396
15. Yu, J. T., Wang, N. D., Ma, T., Jiang, H., Guan, J., and Tan, L. (2011) Roles of β-adrenergic receptors in Alzheimer's disease. Implications for novel therapeutics. Brain Res. Bull. 84, 111-117
16. Yu, J. T., Tan, L., Ou, J. R., Zhu, J. X., Liu, K., Song, J. H., and Sun, Y. P. (2008) Polymorphisms at the β2-adrenergic receptor gene influence Alzheimer's disease susceptibility. Brain Res. 1210, 216-222
17. Morilak, D. A., Barrera, G., Echevarria, D. J., Garcia, A. S., Hernandez, A., Ma, S., and Petre, C. O. (2005) Role of brain norepinephrine in the behavioral response to stress. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 1214-1224
18. Ramos, B. P., and Arnsten, A. F. (2007) Adrenergic pharmacology and cognition. Focus on the prefrontal cortex. Pharmacol. Ther. 113, 523-536
19. Igbavboa, U., Johnson-Anuna, L. N., Rossello, X., Butterick, T. A., Sun, G. Y., and Wood, W. G. (2006) Amyloid β-protein1-42 increases cAMP and apolipoprotein E levels which are inhibited by β1 and β2-adrenergic receptor antagonists in mouse primary astrocytes. Neuroscience 142, 655-660
20. Prapong, T., Uemura, E., and Hsu, W. H. (2001) G protein and cAMP-dependent protein kinase mediate amyloid β-peptide inhibition of neuronal glucose uptake. Exp. Neurol. 167, 59-64
21. Echeverria, V., Ducatenzeiler, A., Chen, C. H., and Cuello, A. C. (2005) Endogenous β-amyloid peptide synthesis modulates cAMP response element-regulated gene expression in PC12 cells. Neuroscience 135, 1193-1202
22. Wang, D., Govindaiah, G., Liu, R., De Arcangelis, V., Cox, C. L., and Xiang, Y. K. (2010) Binding of amyloid βpeptide to β2 adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity. FASEB J. 24, 3511-3521
23. Wang, D., Yuen, E. Y., Zhou, Y., Yan, Z., and Xiang, Y. K. (2011) Amyloid βpeptide-(1-42) induces internalization and degradation of β2 adrenergic receptors in prefrontal cortical neurons. J. Biol. Chem. 286, 31852-31863
24. Guo, C., and Whitmarsh, A. J. (2008) The β-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its nonconserved N terminus. J. Biol. Chem. 283, 15903-15911
25. Hochbaum, D., Tanos, T., Ribeiro-Neto, F., Altschuler, D., and Coso, O. A. (2003) Activation of JNK by Epac is independent of its activity as a Rap guanine nucleotide exchanger. J. Biol. Chem. 278, 33738-33746
26. Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., Berry, R., and Vassar, R. (2006) Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations. Potential factors in amyloid plaque formation. J. Neurosci. 26, 10129-10140
27. Nagai, T., Yamada, K., Kim, H. C., Kim, Y. S., Noda, Y., Imura, A., Nabeshima, Y., and Nabeshima, T. (2003) Cognition impairment in the genetic model of aging klotho gene mutant mice.Arole of oxidative stress. FASEB J. 17, 50-52
28. Wang, D., Noda, Y., Zhou, Y., Mouri, A., Mizoguchi, H., Nitta, A., Chen, W., and Nabeshima, T. (2007) The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in βamyloid25-35.c.v.-injected mice. Involvement of dopaminergic systems. Neuropsychopharmacology 32, 1261-1271
29. Johnson, J. D., Cortez, V., Kennedy, S. L., Foley, T. E., Hanson, H., 3rd, and Fleshner, M. (2008) Role of central β-adrenergic receptors in regulating proinflammatory cytokine responses to a peripheral bacterial challenge. Brain Behav. Immun. 22, 1078-1086
30. Johnson, G. V. (1992) Differential phosphorylation of tau by cyclic AMPdependent protein kinase and Ca2β/calmodulin-dependent protein kinase II. Metabolic and functional consequences. J. Neurochem. 59, 2056-2062
31. Litersky, J. M., Johnson, G. V., Jakes, R., Goedert, M., Lee, M., and Seubert, P. (1996) Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356. Biochem. J. 316, 655-660
32. Yoshimura, Y., Ichinose, T., and Yamauchi, T. (2003) Phosphorylation of tau protein to sites found in Alzheimer's disease brain is catalyzed by Ca2β/calmodulin-dependent protein kinase II as demonstrated tandem mass spectrometry. Neurosci. Lett. 353, 185-188
33. Ploia, C., Antoniou, X., Sclip, A., Grande, V., Cardinetti, D., Colombo, A., Canu, N., Benussi, L., Ghidoni, R., Forloni, G., and Borsello, T. (2011) JNK plays a key role in tau hyperphosphorylation in Alzheimer's disease models. J. Alzheimers Dis. 26, 315-329
34. Sato, S., Tatebayashi, Y., Akagi, T., Chui, D. H., Murayama, M., Miyasaka, T., Planel, E., Tanemura, K., Sun, X., Hashikawa, T., Yoshioka, K., Ishiguro, K., and Takashima, A. (2002) Aberrant tau phosphorylation by glycogen synthase kinase-3βand JNK3 induces oligomeric tau fibrils in COS-7 cells. J. Biol. Chem. 277, 42060-42065
35. Jaworski, T., Kugler, S., and Van Leuven, F. (2010) Modeling of tau-mediated synaptic and neuronal degeneration in Alzheimer's disease. Int. J. Alzheimers Dis. 2010, 1-10
36. Jaworski, T., Lechat, B., Demedts, D., Gielis, L., Devijver, H., Borghgraef, P., Duimel, H., Verheyen, F., Kügler, S., and Van Leuven, F. (2011) Dendritic degeneration, neurovascular defects, and inflammation precede neuronal loss in a mouse model for tau-mediated neurodegeneration. Am. J. Pathol. 179, 2001-2015
37. Jaworski, T., Dewachter, I., Lechat, B., Croes, S., Termont, A., Demedts, D., Borghgraef, P., Devijver, H., Filipkowski, R. K., Kaczmarek, L., Kügler, S., and Van Leuven, F. (2009) AAV-tau mediates pyramidal neurodegeneration by cell-cycle re-entry without neurofibrillary tangle formation in wild-type mice. PLoS ONE 4, e7280